Easton Capital | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,544 results for “Easton Capital”

Trials

View all 1204 →

Not yet recruiting

PACTR201806003389716

Capital Mãe

446 participants

Not yet recruiting

CAPITAL OFFLOAD-SHOCK

456 participants · First posted Aug 11, 2026

Slipped Capital Femoral Epiphysis Treatment

30 participants · First posted Jul 25, 2017

Drugs

View all 75 →

ATR inhibitors(Easton)

Cannabinoid extract therapeutics(Easton Pharmaceuticals)

PAD4 inhibitors(Capital Medical University)

Organizations

View all 222 →

Steward Easton Hospital, Inc.

United States

Hercules Capital

United States

Rand Capital

News

View all 3043 →

Trellis Bioscience Raises $9 Million Series C to Advance Novel Biofilm-Disrupting Antibody for Prosthetic Joint Infections

Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment

IGM Biosciences Downgraded by BMO Capital Following Strategic Update

Page 1 of 455